Search…

Lates News

07/05/2025

Royal Bank of Canada: Maintains rating on Neurocrine Biosciences (NBIX.US), adjusted from outperform to outperform rating, with a target price adjusted from $137.00 to $145.00.

Latest

3 m ago

On Tuesday (May 6th), New York's closing, the S&P 500 index futures fell by 0.99%, the Dow Jones Industrial Average (Dow) futures fell by 1.18%, and the Nasdaq 100 index futures fell by 1.03%. The Russell 2000 index futures fell by 1.39%.

3 m ago

On Tuesday's New York close, the S&P 500 stock index futures finally fell by 0.99%, the Dow Jones Industrial Average futures fell by 1.18%, and the Nasdaq 100 stock index futures fell by 1.03%. The Russell 2000 stock index futures fell by 1.39%.

4 m ago

Reserve Bank of New Zealand Financial Stability Report: Banks continue to maintain profitability, and with the lowering of mortgage loan interest rates due to repricing, it is expected that non-performing loans will decrease.

5 m ago

Reserve Bank of New Zealand Financial Stability Report: Recent insurance stress tests have highlighted increased resilience in the industry.

5 m ago

Reserve Bank of New Zealand: The global economic environment has become increasingly prone to instability.

+852 - 60190728

Customer Support

Commercial Services